BioPharm International
November 11, 2019
Upstream Processing
32
11
Bob Lenich, Emerson's business director for global life sciences, shares insights on where biopharma modeling is now, and where it is heading in the near future.
November 08, 2019
BioBusiness
32
11
Legal experts in biopharmaceutical patent law shed some light on trends and recent news.
November 08, 2019
Upstream Processing
32
11
Modeling is being used for everything from yield improvement to facility design, but new initiatives plan to broaden its reach, both upstream and downstream.
November 01, 2019
Manufacturing
32
11
Applying lessons of raw materials’ characterization and supply-chain control from the semiconductor industry allow more rigorous control of the biopharmaceutical manufacturing process.
November 01, 2019
Downstream Processing
32
11
The latest advances in downstream technologies include stainless-steel liquid chromatography columns, sensing and control units for hygienic valves, a wettable phase for separation and purification, a buffer delivery platform, and a new filter integrity tester.
November 01, 2019
Product Spotlight
32
11
GE Healthcare Life Sciences launched the new KUBio box for the production of viral vector-based gene therapies.
November 01, 2019
Product Spotlight
32
11
Kimberly-Clark Professional introduced the Kimtech A8 Zippered Lab Coat for liquid and particle protection for ISO 7 and 8 or higher cleanroom environments.
November 01, 2019
Regulatory Beat
32
11
FDA readies more efficient oversight processes while advancing collaboration with Europe.
November 01, 2019
Ask the Expert
32
11
It is good industry practice to clarify the precise remit for each of the reviewers of a controlled document, says Siegfried Schmitt, PhD, vice-president, technical, Parexel Consulting.
November 01, 2019
Peer-Reviewed Research
32
11
The authors of this study demonstrate an innovative method that is useful and complements traditional HA assays.
November 01, 2019
Manufacturing
32
11
Limitations in traditional flu vaccine manufacturing methods underline the need for shifting to modern technologies.
November 01, 2019
Cover Story
32
11
Manufacturing differences between traditional mAb therapies and newer biotherapeutics dictate whether processes should be scaled up, scaled out, or use an alternate approach for commercial production.
November 01, 2019
Cover Story
32
11
The use of scale-down models allows for the theoretical optimization of processes and for troubleshooting problems during the developmental stage.
November 01, 2019
From the Editor
32
11
FDA report says drug shortages are underappreciated and patients pay a price.
November 01, 2019
Analytics
32
11
Developing an effective bioassay is crucial for determining the potency of a drug substance or finished drug product. This article gives an overview of how to avoid most problems associated with correct bioassay development.
November 01, 2019
Quality/Regulations
32
11
Accelerated timelines and small batch volumes of cell and gene therapies pose unique challenges for product-release testing.
November 01, 2019
Perspectives on Outsourcing
32
11
Contract manufacturers are making strategic partnerships and expanding services in the last quarter of 2019.
November 01, 2019
Operations
32
11
The following details some of the latest tools and systems available for biopharmaceutical laboratory operations.
November 01, 2019
Issue PDF
32
11
Click the title above to open the BioPharm International November 2019 issue in an interactive PDF format.